Juvenile Myelomonocytic Leukemia
Last Posted: Aug 16, 2021
- Mutational landscape of Juvenile Myelomonocytic Leukemia (JMML)-A real-world context.
Nathany Shrinidhi, et al. International journal of laboratory hematology 2021 8
- RAS Pathway Mutation Patterns in Patients With Juvenile Myelomonocytic Leukemia: A Developing Country Single-center Experience.
Hamdy Nayera, et al. Clinical lymphoma, myeloma & leukemia 2020 2
- PTPN11 mutation with additional somatic alteration indicates unfavorable outcome in juvenile myelomonocytic leukemia: a retrospective clinical study from a single center.
Miao Yan, et al. European journal of pediatrics 2019 12
- JMML genomics and decisions.
Niemeyer Charlotte M et al. Hematology. American Society of Hematology. Education Program 2018 Nov 2018(1) 307-312
- Local Coverage Determination (LCD): Flow Cytometry (L33661)
The U.S. Centers for Medicare & Medicaid Services
- CTLA-4 polymorphisms: influence on transplant-related mortality and survival in children undergoing allogeneic hematopoietic stem cell transplantation.
Hammrich Judith, et al. Journal of cancer research and clinical oncology 2018 1
- Juvenile Myelomonocytic Leukemia in Turkey: A Retrospective Analysis of Sixty-five Patients.
Tüfekçi Özlem, et al. Turkish journal of haematology : official journal of Turkish Society of Haematology 2017 2
- Early T-Cell Precursor Acute Lymphoblastic Leukemia in an Infant With an NRAS Q61R Mutation and Clinical Features of Juvenile Myelomonocytic Leukemia.
Raikar Sunil S, et al. Pediatric blood & cancer 2016 5
- Somatic thrombopoietin (THPO) gene mutations in childhood myeloid leukemias.
Houwing Maite E, et al. International journal of hematology 2015 7 (1) 140-3
- Neurofibromatosis-1 gene deletions and mutations in de novo adult acute myeloid leukemia.
Boudry-Labis Elise, et al. American journal of hematology 2013 4 (4) 306-11
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.